1993
DOI: 10.1172/jci116262
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria.

Abstract: Intraerythrocytic malaria parasites degrade hemoglobin as a principal source of amino acids for parasite protein synthesis. We have previously identified a Plasmodium falciparum trophozoite cysteine proteinase as a putative hemoglobinase and shown that specific inhibitors of this proteinase block the hydrolysis of globin and the development of cultured parasites. We now show that the murine malaria parasite Plasmodium vinckei has an analogous cysteine proteinase with similar biochemical properties to the P. fa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
90
0

Year Published

1996
1996
2023
2023

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 155 publications
(94 citation statements)
references
References 11 publications
4
90
0
Order By: Relevance
“…Our results are consistent with prior observations that the trophozoite stage is most sensitive to treatment with cysteine protease inhibitors (29) and with the conclusion that the principal activity of these agents is to block hemoglobin hydrolysis. Falcipain-2 and falcipain-3 seem to be the principal hemoglobinases that are acted on by cysteine protease inhibitors, as supported by correlations in many classes of inhibitors between action against these enzymes, inhibition of hemoglobin hydrolysis, and prevention of parasite development (16,17,30,31). It remains unclear whether effects of cysteine protease inhibitors on erythrocyte rupture were due only to the consequences of the inhibition of hemoglobin hydrolysis, or whether inhibition of other activities of cysteine proteases also played a role.…”
Section: Discussionmentioning
confidence: 96%
“…Our results are consistent with prior observations that the trophozoite stage is most sensitive to treatment with cysteine protease inhibitors (29) and with the conclusion that the principal activity of these agents is to block hemoglobin hydrolysis. Falcipain-2 and falcipain-3 seem to be the principal hemoglobinases that are acted on by cysteine protease inhibitors, as supported by correlations in many classes of inhibitors between action against these enzymes, inhibition of hemoglobin hydrolysis, and prevention of parasite development (16,17,30,31). It remains unclear whether effects of cysteine protease inhibitors on erythrocyte rupture were due only to the consequences of the inhibition of hemoglobin hydrolysis, or whether inhibition of other activities of cysteine proteases also played a role.…”
Section: Discussionmentioning
confidence: 96%
“…In malaria parasites, where a remarkably similar network of both cysteine and aspartic proteases functions to degrade hemoglobin, treatment of parasite cultures with a combination of cysteine and aspartic protease inhibitors is synergistic (55). Nevertheless, inhibitors of cysteine proteases alone cured malaria in a mouse model (56).…”
Section: Discussionmentioning
confidence: 99%
“…Specific CP inhibitors not only can kill L. major in vitro, but also can cure L. major infection in BALB/c mice (53). In fact, inhibitors of CPs from T. cruzi (54), T. brucei (55), and Plasmodium (56,57) have demonstrated efficacy in preliminary animal studies, and K11777, a CP inhibitor of the T. cruzi enzyme cruzipain, will enter clinical trials for Chagas disease very soon (32). It is also interesting that CP inhibitors such as N-benzoyloxycarbonyl-phe-aladiazomethylketone, which do not directly kill L. mexicana axenic (cultured) amastigotes in liquid culture, do induce the killing of parasites in infected macrophages, supporting a role for CPs in suppression of host defense (6).…”
Section: Discussionmentioning
confidence: 99%